TOBI Podhaler (tobramycin inhalation powder) for oral inhalation, 28 mg
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)
6 ADVERSE REACTIONS
6.2 Post-Marketing Experience
- added ... aphonia to nervous system disorders.
7 DRUG INTERACTIONS
- TOBI Podhaler should not be administered concomitantly with intravenous mannitol
Tell your healthcare provider about ...
- “water pills” (diuretics) such as Edecrin (ethacrynic acid), Lasix (furosemide), or intravenous mannitol